CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 20 enrolled
Drug / intervention
THRIVE +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03091179
NCT03091179N/ACompleted
CompareCT.gov

The Safety and Efficacy of the Transnasal Humidified Rapid-Insufflation Ventilatory Exchange (THRIVE) for Short Laryngologic Surgical Procedures.

Stanford University·interventional·Posted Mar 27, 2017·Updated Mar 4, 2020

In Brief

A clinical study evaluating THRIVE and Endotracheal tube for Laryngologic Surgical Procedures. Completed, enrolled 20 participants across 1 site.

Detailed Summary

The purpose of this study is to investigate whether selected, short laryngologic surgical procedures can be safely and potentially more effectively performed without the use of endotracheal tube or jet ventilation, under completely tubeless conditions. The patient's gas exchange will be supported by rapid insufflation of high-flow oxygen through specialized nasal cannulae: the so called Transnasal Humidified Rapid- Insufflation Ventilatory Exchange (THRIVE).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsLaryngologic Surgical Procedures
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedMar 27, 2017
Enrollment StartMar 17, 2017
Primary CompletionJul 18, 2018
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 9.3 years ago

Interventions

THRIVEdevice

active nasal oxygen delivery system

Endotracheal tubedevice

a plastic tube for mechanical ventilation